CardieX Limited CDX.AX Stock
CardieX Limited Price Chart
CardieX Limited CDX.AX Financial and Trading Overview
| CardieX Limited stock price | 0.07 AUD |
| Previous Close | 0.19 AUD |
| Open | 0.19 AUD |
| Bid | 0.19 AUD x 0 |
| Ask | 0.2 AUD x 0 |
| Day's Range | 0.19 - 0.2 AUD |
| 52 Week Range | 0.18 - 0.45 AUD |
| Volume | 430.86K AUD |
| Avg. Volume | 167.72K AUD |
| Market Cap | 27.26M AUD |
| Beta (5Y Monthly) | 1.98659 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CDX.AX Valuation Measures
| Enterprise Value | 25.11M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.417244 |
| Price/Book (mrq) | 5.428571 |
| Enterprise Value/Revenue | 5.911 |
| Enterprise Value/EBITDA | -1.647 |
Trading Information
CardieX Limited Stock Price History
| Beta (5Y Monthly) | 1.98659 |
| 52-Week Change | -42.42% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.45 AUD |
| 52 Week Low | 0.18 AUD |
| 50-Day Moving Average | 0.25 AUD |
| 200-Day Moving Average | 0.3 AUD |
CDX.AX Share Statistics
| Avg. Volume (3 month) | 167.72K AUD |
| Avg. Daily Volume (10-Days) | 130.53K AUD |
| Shares Outstanding | 143.47M |
| Float | 79.77M |
| Short Ratio | N/A |
| % Held by Insiders | 39.87% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -359.37% |
| Gross Margin | 80.68% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -65.12% |
| Return on Equity (ttm) | -173.68% |
Income Statement
| Revenue (ttm) | 4.25M AUD |
| Revenue Per Share (ttm) | 0.04 AUD |
| Quarterly Revenue Growth (yoy) | -20.39% |
| Gross Profit (ttm) | 3.73M AUD |
| EBITDA | -15245602 AUD |
| Net Income Avi to Common (ttm) | -13991154 AUD |
| Diluted EPS (ttm) | -0.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.48M AUD |
| Total Cash Per Share (mrq) | 0.02 AUD |
| Total Debt (mrq) | 2.89M AUD |
| Total Debt/Equity (mrq) | 63.69 AUD |
| Current Ratio (mrq) | 1.321 |
| Book Value Per Share (mrq) | 0.035 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9623546 AUD |
| Levered Free Cash Flow (ttm) | -4780657 AUD |
Profile of CardieX Limited
| Country | Australia |
| State | NSW |
| City | Sydney |
| Address | 55 Lime Street |
| ZIP | 2000 |
| Phone | 61 2 9874 8761 |
| Website | https://cardiex.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company undertakes contracts with pharmaceutical companies for the use of SphygmoCor XCEL devices; provides lab and data management services for clinical trials comprising end-to-end service that delivers clean datasets to study sponsors. It also develops home vascular health solutions, remote patient monitoring, decentralized clinical trials and solutions wearables, and medical health apps under the CONNEQT name, as well as CONNEQT Pulse device, a home-based heart health vital signs monitoring system, that measures central blood pressure, arterial waveforms, and various other proprietary arterial health parameters through its SphygmoCor technology. The company serves hospitals, clinics, research institutions and pharmaceutical companies. It has strategic collaboration agreement with LifeQ, Inc for wearable devices. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.
Q&A For CardieX Limited Stock
What is a current CDX.AX stock price?
CardieX Limited CDX.AX stock price today per share is 0.07 AUD.
How to purchase CardieX Limited stock?
You can buy CDX.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CardieX Limited?
The stock symbol or ticker of CardieX Limited is CDX.AX.
Which industry does the CardieX Limited company belong to?
The CardieX Limited industry is Medical Devices.
How many shares does CardieX Limited have in circulation?
The max supply of CardieX Limited shares is 294.18M.
What is CardieX Limited Price to Earnings Ratio (PE Ratio)?
CardieX Limited PE Ratio is now.
What was CardieX Limited earnings per share over the trailing 12 months (TTM)?
CardieX Limited EPS is -0.06 AUD over the trailing 12 months.
Which sector does the CardieX Limited company belong to?
The CardieX Limited sector is Healthcare.